Nelson Vergel
Founder, ExcelMale.com
The USP Medicine Supply Map analysis (Chart I) counts the number of active API DMFs by location.
India accounts for 48%
China accounts for 13%
U.S. accounts for 10%
India contributed 62% of active API DMFs filed in 2021, up from 20% filed in 2000. This increase is consistent with the country’s well-publicized national ambition to enhance API manufacturing capabilities.
Europe’s contribution declined from 49% of active API DMFs filed in 2000 to 7% filed in 2021
China contributed 18% of new API DMFs filed in 2019, and 23% filed in 2021
U.S. contributed 4% of new API DMFs filed in 2019 and 2021
Source: Geographic concentration of pharmaceutical manufacturing: USP Medicine Supply Map analysis | Quality Matters | U.S. Pharmacopeia Blog
India accounts for 48%
China accounts for 13%
U.S. accounts for 10%
India contributed 62% of active API DMFs filed in 2021, up from 20% filed in 2000. This increase is consistent with the country’s well-publicized national ambition to enhance API manufacturing capabilities.
Europe’s contribution declined from 49% of active API DMFs filed in 2000 to 7% filed in 2021
China contributed 18% of new API DMFs filed in 2019, and 23% filed in 2021
U.S. contributed 4% of new API DMFs filed in 2019 and 2021
Source: Geographic concentration of pharmaceutical manufacturing: USP Medicine Supply Map analysis | Quality Matters | U.S. Pharmacopeia Blog